Asia-Pacific Orthobiologics Market Outlook to 2025

Asia-Pacific Orthobiologics Market Outlook to 2025


  • Products Id :- GDMECR0861DB
  • |
  • Pages: 184
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Asia-Pacific Orthobiologics Market Outlook to 2025

Summary

GlobalData's new report, Asia-Pacific Orthobiologics Market Outlook to 2025, provides key market data on the Asia-Pacific Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Orthobiologics market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Orthobiologics market.

- Global corporate-level profiles of key companies operating within the Asia-Pacific Orthobiologics market.

- Key players covered include Medtronic plc, Sanofi, Stryker Corp and Others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Orthobiologics Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Orthobiologics Market, Asia-Pacific 12

3.1 Orthobiologics Market, Asia-Pacific, Revenue (USD m), 2015-2025 12

3.2 Orthobiologics Market, Asia-Pacific, Revenue (USD m), 2015-2025 14

3.3 Orthobiologics Market, Asia-Pacific, Volume (Units), 2015-2025 17

3.4 Orthobiologics Market, Asia-Pacific, Volume (Units), 2015-2025 19

3.5 Orthobiologics Market, Asia-Pacific, Company Share by Revenue (USD m), 2017 22

4 Orthobiologics Market, Australia 24

4.1 Orthobiologics Market, Australia, Revenue (USD m), 2015-2025 24

4.2 Orthobiologics Market, Australia, Volume (Units), 2015-2025 35

4.3 Orthobiologics Market, Australia, Average Price (USD ), 2015-2025 47

4.4 Orthobiologics Market, Australia, Distribution Share by Revenue (USD m), 2017 49

4.5 Orthobiologics Market, Australia, Company Share by Revenue (USD m), 2017 50

5 Orthobiologics Market, China 52

5.1 Orthobiologics Market, China, Revenue (USD m), 2015-2025 52

5.2 Orthobiologics Market, China, Volume (Units), 2015-2025 62

5.3 Orthobiologics Market, China, Average Price (USD ), 2015-2025 74

5.4 Orthobiologics Market, China, Distribution Share by Revenue (USD m), 2017 76

5.5 Orthobiologics Market, China, Company Share by Revenue (USD m), 2017 77

6 Orthobiologics Market, India 79

6.1 Orthobiologics Market, India, Revenue (USD m), 2015-2025 79

6.2 Orthobiologics Market, India, Volume (Units), 2015-2025 91

6.3 Orthobiologics Market, India, Average Price (USD ), 2015-2025 103

6.4 Orthobiologics Market, India, Distribution Share by Revenue (USD m), 2017 105

6.5 Orthobiologics Market, India, Company Share by Revenue (USD m), 2017 106

7 Orthobiologics Market, Japan 108

7.1 Orthobiologics Market, Japan, Revenue (USD m), 2015-2025 108

7.2 Orthobiologics Market, Japan, Volume (Units), 2015-2025 119

7.3 Orthobiologics Market, Japan, Average Price (USD ), 2015-2025 130

7.4 Orthobiologics Market, Japan, Distribution Share by Revenue (USD m), 2017 132

7.5 Orthobiologics Market, Japan, Company Share by Revenue (USD m), 2017 133

8 Orthobiologics Market, South Korea 135

8.1 Orthobiologics Market, South Korea, Revenue (USD m), 2015-2025 135

8.2 Orthobiologics Market, South Korea, Volume (Units), 2015-2025 147

8.3 Orthobiologics Market, South Korea, Average Price (USD ), 2015-2025 157

8.4 Orthobiologics Market, South Korea, Distribution Share by Revenue (USD m), 2017 159

8.5 Orthobiologics Market, South Korea, Company Share by Revenue (USD m), 2017 160

9 Overview of Key Companies in Asia-Pacific Orthobiologics Market 162

9.1 Sanofi 162

9.2 Seikagaku Corp 162

9.3 DePuy Synthes Inc 162

9.4 Stryker Corp 162

9.5 Medtronic Plc 163

9.6 Chugai Pharmaceutical Co Ltd 163

9.7 Zimmer Biomet Holdings Inc 163

9.8 Shandong Haiyou Freda Pharmacy Co Ltd 163

9.9 Bioventus LLC 164

10 Orthobiologics Market Pipeline Products 165

11 Recent Developments 168

11.1 Corporate Communications 168

11.2 Financial Announcements 169

11.3 Product News 176

12 Appendix 177

12.1 Research Methodology 178

12.2 GlobalData Consulting 182

12.3 Contact Us 183

12.4 Disclaimer 183

1.2 List of Figures

Figure 1: Orthobiologics Market, Cross Country Comparison, Asia-Pacific, Revenue (USD m), USD Constant, 2015-2025 13

Figure 2: Orthobiologics Market, Asia-Pacific, Revenue (USD m), Historic, USD Constant, 2015-2025 15

Figure 3: Orthobiologics Market, Asia-Pacific, Volume (Units), 2015-2025 18

Figure 4: Orthobiologics Market, Asia-Pacific, Volume (Units), 2015-2025 20

Figure 5: Orthobiologics Market, Asia-Pacific, Company Share (%) 2017 23

Figure 6: Orthobiologics Market, Australia, Revenue (USD m), USD Constant, 2015-2025 25

Figure 7: Bone Grafts and Substitutes Market, Australia, Revenue (USD m), USD Constant, 2015-2025 28

Figure 8: Bone Growth Stimulators Market, Australia, Revenue (USD m), USD Constant, 2015-2025 30

Figure 9: Soft Tissue Biologics Market, Australia, Revenue (USD m), USD Constant, 2015-2025 32

Figure 10: Viscosupplementation Market, Australia, Revenue (USD m), USD Constant, 2015-2025 34

Figure 11: Orthobiologics Market, Australia, Volume (Units), 2015-2025 36

Figure 12: Bone Grafts and Substitutes Market, Australia, Volume (Units), 2015-2025 39

Figure 13: Bone Growth Stimulators Market, Australia, Volume (Units), 2015-2025 42

Figure 14: Soft Tissue Biologics Market, Australia, Volume (Units), 2015-2025 44

Figure 15: Viscosupplementation Market, Australia, Volume (Units), 2015-2025 46

Figure 16: Orthobiologics Market, Australia, Company Share (%) 2017 51

Figure 17: Orthobiologics Market, China, Revenue (USD m), USD Constant, 2015-2025 53

Figure 18: Bone Grafts and Substitutes Market, China, Revenue (USD m), USD Constant, 2015-2025 55

Figure 19: Bone Growth Stimulators Market, China, Revenue (USD m), USD Constant, 2015-2025 57

Figure 20: Soft Tissue Biologics Market, China, Revenue (USD m), USD Constant, 2015-2025 59

Figure 21: Viscosupplementation Market, China, Revenue (USD m), USD Constant, 2015-2025 61

Figure 22: Orthobiologics Market, China, Volume (Units), 2015-2025 63

Figure 23: Bone Grafts and Substitutes Market, China, Volume (Units), 2015-2025 66

Figure 24: Bone Growth Stimulators Market, China, Volume (Units), 2015-2025 69

Figure 25: Soft Tissue Biologics Market, China, Volume (Units), 2015-2025 71

Figure 26: Viscosupplementation Market, China, Volume (Units), 2015-2025 73

Figure 27: Orthobiologics Market, China, Company Share (%) 2017 78

Figure 28: Orthobiologics Market, India, Revenue (USD m), USD Constant, 2015-2025 80

Figure 29: Bone Grafts and Substitutes Market, India, Revenue (USD m), USD Constant, 2015-2025 83

Figure 30: Bone Growth Stimulators Market, India, Revenue (USD m), USD Constant, 2015-2025 86

Figure 31: Soft Tissue Biologics Market, India, Revenue (USD m), USD Constant, 2015-2025 88

Figure 32: Viscosupplementation Market, India, Revenue (USD m), USD Constant, 2015-2025 90

Figure 33: Orthobiologics Market, India, Volume (Units), 2015-2025 92

Figure 34: Bone Grafts and Substitutes Market, India, Volume (Units), 2015-2025 95

Figure 35: Bone Growth Stimulators Market, India, Volume (Units), 2015-2025 98

Figure 36: Soft Tissue Biologics Market, India, Volume (Units), 2015-2025 100

Figure 37: Viscosupplementation Market, India, Volume (Units), 2015-2025 102

Figure 38: Orthobiologics Market, India, Company Share (%) 2017 107

Figure 39: Orthobiologics Market, Japan, Revenue (USD m), USD Constant, 2015-2025 109

Figure 40: Bone Grafts and Substitutes Market, Japan, Revenue (USD m), USD Constant, 2015-2025 112

Figure 41: Bone Growth Stimulators Market, Japan, Revenue (USD m), USD Constant, 2015-2025 114

Figure 42: Soft Tissue Biologics Market, Japan, Revenue (USD m), USD Constant, 2015-2025 116

Figure 43: Viscosupplementation Market, Japan, Revenue (USD m), USD Constant, 2015-2025 118

Figure 44: Orthobiologics Market, Japan, Volume (Units), 2015-2025 120

Figure 45: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2015-2025 123

Figure 46: Bone Growth Stimulators Market, Japan, Volume (Units), 2015-2025 125

Figure 47: Soft Tissue Biologics Market, Japan, Volume (Units), 2015-2025 127

Figure 48: Viscosupplementation Market, Japan, Volume (Units), 2015-2025 129

Figure 49: Orthobiologics Market, Japan, Company Share (%) 2017 134

Figure 50: Orthobiologics Market, South Korea, Revenue (USD m), USD Constant, 2015-2025 136

Figure 51: Bone Grafts and Substitutes Market, South Korea, Revenue (USD m), USD Constant, 2015-2025 139

Figure 52: Bone Growth Stimulators Market, South Korea, Revenue (USD m), USD Constant, 2015-2025 142

Figure 53: Soft Tissue Biologics Market, South Korea, Revenue (USD m), USD Constant, 2015-2025 144

Figure 54: Viscosupplementation Market, South Korea, Revenue (USD m), USD Constant, 2015-2025 146

Figure 55: Orthobiologics Market, South Korea, Volume (Units), 2015-2025 148

Figure 56: Bone Grafts and Substitutes Market, South Korea, Volume (Units), 2015-2025 150

Figure 57: Bone Growth Stimulators Market, South Korea, Volume (Units), 2015-2025 152

Figure 58: Soft Tissue Biologics Market, South Korea, Volume (Units), 2015-2025 154

Figure 59: Viscosupplementation Market, South Korea, Volume (Units), 2015-2025 156

Figure 60: Orthobiologics Market, South Korea, Company Share (%) 2017 161

1.1 List of Tables

Table 1: Orthobiologics Market, Cross Country Comparison, Asia-Pacific, Revenue (USD m), USD Constant, 2015-2025 14

Table 2: Orthobiologics Market, Asia-Pacific, Revenue (USD m), Historic, USD Constant, 2015-2020 16

Table 3: Orthobiologics Market, Asia-Pacific, Revenue (USD m), Forecast, USD Constant, 2021-2025 17

Table 4: Orthobiologics Market, Asia-Pacific, Volume (Units), 2015-2025 19

Table 5: Orthobiologics Market, Asia-Pacific, Volume (Units), 2015-2020 21

Table 6: Orthobiologics Market, Asia-Pacific, Volume (Units), 2021-2025 22

Table 7: Orthobiologics Market, Asia-Pacific, Company Share by Revenue (USD m), USD Constant, 2017 24

Table 8: Orthobiologics Market, Australia, Revenue (USD m), USD Constant, 2015-2020 26

Table 9: Orthobiologics Market, Australia, Revenue (USD m), USD Constant, 2021-2025 27

Table 10: Bone Grafts and Substitutes Market, Australia, Revenue (USD m), USD Constant, 2015-2020 29

Table 11: Bone Grafts and Substitutes Market, Australia, Revenue (USD m), USD Constant, 2021-2025 29

Table 12: Bone Growth Stimulators Market, Australia, Revenue (USD m), USD Constant, 2015-2020 31

Table 13: Bone Growth Stimulators Market, Australia, Revenue (USD m), USD Constant, 2021-2025 31

Table 14: Soft Tissue Biologics Market, Australia, Revenue (USD m), USD Constant, 2015-2020 33

Table 15: Soft Tissue Biologics Market, Australia, Revenue (USD m), USD Constant, 2021-2025 33

Table 16: Viscosupplementation Market, Australia, Revenue (USD m), USD Constant, 2015-2020 35

Table 17: Viscosupplementation Market, Australia, Revenue (USD m), USD Constant, 2021-2025 35

Table 18: Orthobiologics Market, Australia, Volume (Units), 2015-2020 37

Table 19: Orthobiologics Market, Australia, Volume (Units), 2021-2025 38

Table 20: Bone Grafts and Substitutes Market, Australia, Volume (Units), 2015-2020 40

Table 21: Bone Grafts and Substitutes Market, Australia, Volume (Units), 2021-2025 41

Table 22: Bone Growth Stimulators Market, Australia, Volume (Units), 2015-2020 43

Table 23: Bone Growth Stimulators Market, Australia, Volume (Units), 2021-2025 43

Table 24: Soft Tissue Biologics Market, Australia, Volume (Units), 2015-2020 45

Table 25: Soft Tissue Biologics Market, Australia, Volume (Units), 2021-2025 45

Table 26: Viscosupplementation Market, Australia, Volume (Units), 2015-2020 47

Table 27: Viscosupplementation Market, Australia, Volume (Units), 2021-2025 47

Table 28: Orthobiologics Market, Australia, Average Price (USD ), 2015-2020 48

Table 29: Orthobiologics Market, Australia, Average Price (USD ), 2021-2025 49

Table 30: Orthobiologics Market, Australia, Distribution Share by Revenue (USD m), USD Constant, 2017 50

Table 31: Orthobiologics Market, Australia, Company Share by Revenue (USD m), USD Constant, 2017 52

Table 32: Orthobiologics Market, China, Revenue (USD m), USD Constant, 2015-2020 54

Table 33: Orthobiologics Market, China, Revenue (USD m), USD Constant, 2021-2025 54

Table 34: Bone Grafts and Substitutes Market, China, Revenue (USD m), USD Constant, 2015-2020 56

Table 35: Bone Grafts and Substitutes Market, China, Revenue (USD m), USD Constant, 2021-2025 56

Table 36: Bone Growth Stimulators Market, China, Revenue (USD m), USD Constant, 2015-2020 58

Table 37: Bone Growth Stimulators Market, China, Revenue (USD m), USD Constant, 2021-2025 58

Table 38: Soft Tissue Biologics Market, China, Revenue (USD m), USD Constant, 2015-2020 60

Table 39: Soft Tissue Biologics Market, China, Revenue (USD m), USD Constant, 2021-2025 60

Table 40: Viscosupplementation Market, China, Revenue (USD m), USD Constant, 2015-2020 62

Table 41: Viscosupplementation Market, China, Revenue (USD m), USD Constant, 2021-2025 62

Table 42: Orthobiologics Market, China, Volume (Units), 2015-2020 64

Table 43: Orthobiologics Market, China, Volume (Units), 2021-2025 65

Table 44: Bone Grafts and Substitutes Market, China, Volume (Units), 2015-2020 67

Table 45: Bone Grafts and Substitutes Market, China, Volume (Units), 2021-2025 68

Table 46: Bone Growth Stimulators Market, China, Volume (Units), 2015-2020 70

Table 47: Bone Growth Stimulators Market, China, Volume (Units), 2021-2025 70

Table 48: Soft Tissue Biologics Market, China, Volume (Units), 2015-2020 72

Table 49: Soft Tissue Biologics Market, China, Volume (Units), 2021-2025 72

Table 50: Viscosupplementation Market, China, Volume (Units), 2015-2020 74

Table 51: Viscosupplementation Market, China, Volume (Units), 2021-2025 74

Table 52: Orthobiologics Market, China, Average Price (USD ), 2015-2020 75

Table 53: Orthobiologics Market, China, Average Price (USD ), 2021-2025 76

Table 54: Orthobiologics Market, China, Distribution Share by Revenue (USD m), USD Constant, 2017 77

Table 55: Orthobiologics Market, China, Company Share by Revenue (USD m), USD Constant, 2017 79

Table 56: Orthobiologics Market, India, Revenue (USD m), USD Constant, 2015-2020 81

Table 57: Orthobiologics Market, India, Revenue (USD m), USD Constant, 2021-2025 82

Table 58: Bone Grafts and Substitutes Market, India, Revenue (USD m), USD Constant, 2015-2020 84

Table 59: Bone Grafts and Substitutes Market, India, Revenue (USD m), USD Constant, 2021-2025 85

Table 60: Bone Growth Stimulators Market, India, Revenue (USD m), USD Constant, 2015-2020 87

Table 61: Bone Growth Stimulators Market, India, Revenue (USD m), USD Constant, 2021-2025 87

Table 62: Soft Tissue Biologics Market, India, Revenue (USD m), USD Constant, 2015-2020 89

Table 63: Soft Tissue Biologics Market, India, Revenue (USD m), USD Constant, 2021-2025 89

Table 64: Viscosupplementation Market, India, Revenue (USD m), USD Constant, 2015-2020 91

Table 65: Viscosupplementation Market, India, Revenue (USD m), USD Constant, 2021-2025 91

Table 66: Orthobiologics Market, India, Volume (Units), 2015-2020 93

Table 67: Orthobiologics Market, India, Volume (Units), 2021-2025 94

Table 68: Bone Grafts and Substitutes Market, India, Volume (Units), 2015-2020 96

Table 69: Bone Grafts and Substitutes Market, India, Volume (Units), 2021-2025 97

Table 70: Bone Growth Stimulators Market, India, Volume (Units), 2015-2020 99

Table 71: Bone Growth Stimulators Market, India, Volume (Units), 2021-2025 99

Table 72: Soft Tissue Biologics Market, India, Volume (Units), 2015-2020 101

Table 73: Soft Tissue Biologics Market, India, Volume (Units), 2021-2025 101

Table 74: Viscosupplementation Market, India, Volume (Units), 2015-2020 103

Table 75: Viscosupplementation Market, India, Volume (Units), 2021-2025 103

Table 76: Orthobiologics Market, India, Average Price (USD ), 2015-2020 104

Table 77: Orthobiologics Market, India, Average Price (USD ), 2021-2025 105

Table 78: Orthobiologics Market, India, Distribution Share by Revenue (USD m), USD Constant, 2017 106

Table 79: Orthobiologics Market, India, Company Share by Revenue (USD m), USD Constant, 2017 108

Table 80: Orthobiologics Market, Japan, Revenue (USD m), USD Constant, 2015-2020 110

Table 81: Orthobiologics Market, Japan, Revenue (USD m), USD Constant, 2021-2025 111

Table 82: Bone Grafts and Substitutes Market, Japan, Revenue (USD m), USD Constant, 2015-2020 113

Table 83: Bone Grafts and Substitutes Market, Japan, Revenue (USD m), USD Constant, 2021-2025 113

Table 84: Bone Growth Stimulators Market, Japan, Revenue (USD m), USD Constant, 2015-2020 115

Table 85: Bone Growth Stimulators Market, Japan, Revenue (USD m), USD Constant, 2021-2025 115

Table 86: Soft Tissue Biologics Market, Japan, Revenue (USD m), USD Constant, 2015-2020 117

Table 87: Soft Tissue Biologics Market, Japan, Revenue (USD m), USD Constant, 2021-2025 117

Table 88: Viscosupplementation Market, Japan, Revenue (USD m), USD Constant, 2015-2020 119

Table 89: Viscosupplementation Market, Japan, Revenue (USD m), USD Constant, 2021-2025 119

Table 90: Orthobiologics Market, Japan, Volume (Units), 2015-2020 121

Table 91: Orthobiologics Market, Japan, Volume (Units), 2021-2025 122

Table 92: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2015-2020 124

Table 93: Bone Grafts and Substitutes Market, Japan, Volume (Units), 2021-2025 124

Table 94: Bone Growth Stimulators Market, Japan, Volume (Units), 2015-2020 126

Table 95: Bone Growth Stimulators Market, Japan, Volume (Units), 2021-2025 126

Table 96: Soft Tissue Biologics Market, Japan, Volume (Units), 2015-2020 128

Table 97: Soft Tissue Biologics Market, Japan, Volume (Units), 2021-2025 128

Table 98: Viscosupplementation Market, Japan, Volume (Units), 2015-2020 130

Table 99: Viscosupplementation Market, Japan, Volume (Units), 2021-2025 130

Table 100: Orthobiologics Market, Japan, Average Price (USD ), 2015-2020 131

Table 101: Orthobiologics Market, Japan, Average Price (USD ), 2021-2025 132

Table 102: Orthobiologics Market, Japan, Distribution Share by Revenue (USD m), USD Constant, 2017 133

Table 103: Orthobiologics Market, Japan, Company Share by Revenue (USD m), USD Constant, 2017 135

Table 104: Orthobiologics Market, South Korea, Revenue (USD m), USD Constant, 2015-2020 137

Table 105: Orthobiologics Market, South Korea, Revenue (USD m), USD Constant, 2021-2025 138

Table 106: Bone Grafts and Substitutes Market, South Korea, Revenue (USD m), USD Constant, 2015-2020 140

Table 107: Bone Grafts and Substitutes Market, South Korea, Revenue (USD m), USD Constant, 2021-2025 141

Table 108: Bone Growth Stimulators Market, South Korea, Revenue (USD m), USD Constant, 2015-2020 143

Table 109: Bone Growth Stimulators Market, South Korea, Revenue (USD m), USD Constant, 2021-2025 143

Table 110: Soft Tissue Biologics Market, South Korea, Revenue (USD m), USD Constant, 2015-2020 145

Table 111: Soft Tissue Biologics Market, South Korea, Revenue (USD m), USD Constant, 2021-2025 145

Table 112: Viscosupplementation Market, South Korea, Revenue (USD m), USD Constant, 2015-2020 147

Table 113: Viscosupplementation Market, South Korea, Revenue (USD m), USD Constant, 2021-2025 147

Table 114: Orthobiologics Market, South Korea, Volume (Units), 2015-2020 149

Table 115: Orthobiologics Market, South Korea, Volume (Units), 2021-2025 149

Table 116: Bone Grafts and Substitutes Market, South Korea, Volume (Units), 2015-2020 151

Table 117: Bone Grafts and Substitutes Market, South Korea, Volume (Units), 2021-2025 151

Table 118: Bone Growth Stimulators Market, South Korea, Volume (Units), 2015-2020 153

Table 119: Bone Growth Stimulators Market, South Korea, Volume (Units), 2021-2025 153

Table 120: Soft Tissue Biologics Market, South Korea, Volume (Units), 2015-2020 155

Table 121: Soft Tissue Biologics Market, South Korea, Volume (Units), 2021-2025 155

Table 122: Viscosupplementation Market, South Korea, Volume (Units), 2015-2020 157

Table 123: Viscosupplementation Market, South Korea, Volume (Units), 2021-2025 157

Table 124: Orthobiologics Market, South Korea, Average Price (USD ), 2015-2020 158

Table 125: Orthobiologics Market, South Korea, Average Price (USD ), 2021-2025 159

Table 126: Orthobiologics Market, South Korea, Distribution Share by Revenue (USD m), USD Constant, 2017 160

Table 127: Orthobiologics Market, South Korea, Company Share by Revenue (USD m), USD Constant, 2017 162

Table 128: Orthobiologics Market Pipeline Products 166

Table 129: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 181

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Sanofi

Seikagaku Corp

DePuy Synthes Inc

Stryker Corp

Medtronic Plc

Chugai Pharmaceutical Co Ltd

Zimmer Biomet Holdings Inc

Shandong Haiyou Freda Pharmacy Co Ltd

Bioventus LLC

Orthopedic Devices, Arthroscopy Devices, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools, Orthopedic Prosthetics, Orthotic Devices, Other Joint Reconstruction, Spinal Surgery, Trauma Fixation, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, DePuy Synthes Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Otto GmbH & Co KG, Medtronic plc, Smith & Nephew Plc, Ossur hf, Arthrex Inc, DJO Global Inc, e-life International Co., Ltd. Essity Aktiebolag

select a license
Single User License
USD 5995 INR 412396
Site License
USD 11990 INR 824792
Corporate User License
USD 17985 INR 1237188

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com